Beijing Aosaikang Pharmaceutical: Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accountants in the 2023 annual review

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.